Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 23755169)

1.

Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.

Zetterqvist AV, Berglund LM, Blanco F, Garcia-Vaz E, Wigren M, Dunér P, Andersson AM, To F, Spegel P, Nilsson J, Bengtsson E, Gomez MF.

PLoS One. 2013 Jun 3;8(6):e65020. doi: 10.1371/journal.pone.0065020. Print 2014.

2.

Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.

Nilsson-Berglund LM, Zetterqvist AV, Nilsson-Ohman J, Sigvardsson M, González Bosc LV, Smith ML, Salehi A, Agardh E, Fredrikson GN, Agardh CD, Nilsson J, Wamhoff BR, Hultgårdh-Nilsson A, Gomez MF.

Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):218-24. doi: 10.1161/ATVBAHA.109.199299. Epub 2009 Dec 3.

3.

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice.

Di Marco E, Gray SP, Chew P, Koulis C, Ziegler A, Szyndralewiez C, Touyz RM, Schmidt HH, Cooper ME, Slattery R, Jandeleit-Dahm KA.

Diabetologia. 2014 Mar;57(3):633-42. doi: 10.1007/s00125-013-3118-3. Epub 2013 Nov 30.

PMID:
24292634
4.

Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.

Recio C, Oguiza A, Lazaro I, Mallavia B, Egido J, Gomez-Guerrero C.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1953-60. doi: 10.1161/ATVBAHA.114.304144. Epub 2014 Jul 10.

PMID:
25012131
5.

Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.

McGraw AP, Bagley J, Chen WS, Galayda C, Nickerson H, Armani A, Caprio M, Carmeliet P, Jaffe IZ.

J Am Heart Assoc. 2013 Feb 22;2(1):e000018. doi: 10.1161/JAHA.112.000018.

6.

Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Yi X, Xu L, Hiller S, Kim HS, Maeda N.

Atherosclerosis. 2012 Jul;223(1):137-43. doi: 10.1016/j.atherosclerosis.2012.04.025. Epub 2012 May 16.

7.

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.

8.

DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.

Ta NN, Schuyler CA, Li Y, Lopes-Virella MF, Huang Y.

J Cardiovasc Pharmacol. 2011 Aug;58(2):157-66. doi: 10.1097/FJC.0b013e31821e5626.

9.

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.

Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Diabetologia. 2006 Apr;49(4):766-74. Epub 2006 Feb 4.

PMID:
16463048
10.

Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice.

Noda K, Hosoya M, Nakajima S, Ohashi J, Fukumoto Y, Shimokawa H.

Tohoku J Exp Med. 2012;228(4):305-15.

11.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

12.

miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.

Distel E, Barrett TJ, Chung K, Girgis NM, Parathath S, Essau CC, Murphy AJ, Moore KJ, Fisher EA.

Circ Res. 2014 Oct 10;115(9):759-69. doi: 10.1161/CIRCRESAHA.115.304164. Epub 2014 Sep 8.

PMID:
25201910
13.

PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice.

Kong L, Shen X, Lin L, Leitges M, Rosario R, Zou YS, Yan SF.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1779-87. doi: 10.1161/ATVBAHA.112.301113. Epub 2013 Jun 13.

14.

Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.

Nogi Y, Nagashima M, Terasaki M, Nohtomi K, Watanabe T, Hirano T.

PLoS One. 2012;7(4):e35683. doi: 10.1371/journal.pone.0035683. Epub 2012 Apr 20.

15.

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.

Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ.

Circulation. 2002 Jul 9;106(2):246-53.

16.

Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.

Jandeleit-Dahm K, Lassila M, Davis BJ, Candido R, Johnston CI, Allen TJ, Burrell LM, Cooper ME.

J Hypertens. 2005 Nov;23(11):2071-82.

PMID:
16208151
17.

The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.

Zhang WJ, Wei H, Frei B.

Exp Biol Med (Maywood). 2010 May;235(5):633-41. doi: 10.1258/ebm.2009.009229.

18.

Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.

Chew P, Yuen DY, Koh P, Stefanovic N, Febbraio MA, Kola I, Cooper ME, de Haan JB.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):823-30. doi: 10.1161/ATVBAHA.109.186619. Epub 2009 Mar 26.

19.

Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.

Wang Q, Zhang M, Liang B, Shirwany N, Zhu Y, Zou MH.

PLoS One. 2011;6(9):e25436. doi: 10.1371/journal.pone.0025436. Epub 2011 Sep 27.

20.

Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.

Bu DX, Rai V, Shen X, Rosario R, Lu Y, D'Agati V, Yan SF, Friedman RA, Nuglozeh E, Schmidt AM.

Circ Res. 2010 Apr 2;106(6):1040-51. doi: 10.1161/CIRCRESAHA.109.201103. Epub 2010 Feb 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk